Skip to Content

China Health Industries Holdings Inc CHHE

Morningstar Rating
$1.45 −0.40 (21.62%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CHHE is trading within a range we consider fairly valued.
Price
$1.44
Fair Value
$4.32
Uncertainty
Extreme
1-Star Price
$49.32
5-Star Price
$2.30
Economic Moat
Bshd
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CHHE is a good fit for your portfolio.

Trading Information

Previous Close Price
$1.85
Day Range
$1.451.93
52-Week Range
$0.104.15
Bid/Ask
$1.20 / $1.95
Market Cap
$95.03 Mil
Volume/Avg
15,046 / 6,437

Key Statistics

Price/Earnings (Normalized)
Price/Sales
810.51
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

China Health Industries Holdings Inc operates in the health product industry and produces, markets and distributes medicines, health products, health devices and cosmetics. Its products series cover hemp-based food, hemp-based medicines, external used medicines and health food. The company has segmented its operating activities into three reportable segments, Humankind, HLJ Huimeijia, and Others. It generates maximum revenue from the Humankind segment.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
34

Valuation

Metric
CHHE
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
810.51
Price/Cash Flow
Price/Earnings
CHHE

Financial Strength

Metric
CHHE
Quick Ratio
0.00
Current Ratio
0.04
Interest Coverage
Quick Ratio
CHHE

Profitability

Metric
CHHE
Return on Assets (Normalized)
−3.95%
Return on Equity (Normalized)
−4.73%
Return on Invested Capital (Normalized)
−4.19%
Return on Assets
CHHE
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AKqbhcpdjslWkkk$79.4 Bil
MKKGY
Merck KGaA ADRMjpcccmjbnXpyqyh$79.0 Bil
HLN
Haleon PLC ADRMldwpghgJwymc$38.5 Bil
VTRS
Viatris IncBcpjchygHnzc$13.1 Bil
RDY
Dr Reddy's Laboratories Ltd ADRWjnvzljwMdvzd$11.7 Bil
CTLT
Catalent IncWcxfdkyjGlfyn$10.0 Bil
CURLF
Curaleaf Holdings IncRgfpdksrPdlg$4.2 Bil
PRGO
Perrigo Co PLCZrqrwkvfPjj$4.1 Bil
PBH
Prestige Consumer Healthcare IncPkzhyqdrSzmnf$3.2 Bil
GTBIF
Green Thumb Industries IncVwqxlbmpvcCyvj$3.1 Bil

Sponsor Center